Law firm expands to US with new Boston base
International law firm Withers, whose life sciences team is based in Cambridge UK, has expanded its technology practice to the US with the hire of a new cohort of life science and VC-focused attorneys in Boston.
The new US team comprises three partners and a patent specialist, working alongside Boston-based Withers tech attorney Andrew Gay.
The creation of a base in Boston, one of the leading centres for life science research and commercialisation in the US – as well as a major venture capital hub – enables Withers tech to join up and expand on client relationships in London and Cambridge in the UK, where the team was launched in 2018, as well as Europe and Asia where Withers tech also recently established a presence.
The Boston team includes partners John Serio, Dr Richard Emmons and Dr Christopher Cowles, all joining from Burns & Levinson, along with patent specialist Kristina Scandore joining from Hamilton, Brook, Smith & Reynolds. Andrew Gay joined the firm in 2018 as part of the JAG Shaw Baker team. The new line-up represents clients on the FDA regulatory and approval process, IP advice including patent and trademark protection and litigation and the licensing of technology, and venture capital deal structuring.
The East Coast power play complements the work the firm does in the UK for BioMedTech and pharmaceuticals clients in the US.
Susanna Stanfield, who heads the Cambridge UK office, told Business Weekly: “We're very excited to have opened a new base in another world-class centre for the research and development of life sciences, healthcare and medical products and solutions.
“Many of our clients in Cambridge also have connections with Boston and by joining up with our new team of expert life sciences attorneys, we can help them to expand their businesses, facilitate the commercialisation of their intellectual property globally and help gain access to the venture capital markets in the US. We look forward to continuing the expansion of the Withers tech team in the US.”
James Shaw, global head of the Withers tech team, added: “We are really excited to continue the expansion of our support for global technology and innovation clients with the US launch of Withers tech. For many of our clients who are managing private capital funds, the technology and life sciences sectors are major focuses and the devastating damage of Covid-19 has hugely reinforced life sciences as an attractive investment target.
“The addition of our Boston team affirms our commitment to technology, life sciences and venture capital clients in the US and establishes a really robust network to back all of our clients working and investing in the sector around the world.”